Endoscopic Hemostasis Devices Market Size & Growth Forecast 2027–2036, By Segments (End Use, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to Content
Market Size and Growth Outlook
Endoscopic Hemostasis Devices Market size was more than USD 2.24 billion in 2026 and is set to grow at a 4.1% CAGR between 2027 and 2036, exceeding USD 3.35 billion by 2036. The industry revenue for 2027 is calculated at USD 2.32 billion.
Get more details on this report
Request Free Sample ReportEndoscopic Hemostasis Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America held 44.38% of the market in 2026, supported by advanced gastrointestinal care infrastructure, widespread minimally invasive procedures, and established capabilities for managing gastrointestinal bleeding.
- Healthcare infrastructure improvements, expanding hospital networks, physician training, and rising adoption of advanced endoscopic procedures are increasing demand for effective gastrointestinal bleeding management solutions.
Segment Momentum
- Hospitals held a 62.24% market share in 2026, supported by high gastrointestinal procedure volumes, advanced endoscopic infrastructure, specialized clinical teams, and the need to manage complex bleeding emergencies.
- Outpatient facilities are expanding as minimally invasive procedures become more accessible outside hospitals. Demand for shorter recovery periods, convenient care, and efficient bleeding-control devices supports this shift.
Market Expansion Drivers
- Rising incidence of gastrointestinal bleeding and endoscopic procedures.
- Technological innovations in hemostasis device design.
- Expansion of hospital and endoscopy infrastructure in emerging regions.
Leading Market Participants
- Key companies in the endoscopic hemostasis devices market include Boston Scientific (USA), Olympus (Japan), Medtronic (Ireland), Cook Medical (USA), CONMED (USA), Fujifilm (Japan), Erbe Elektromedizin (Germany), Micro-Tech Endoscopy (China), Steris (USA), Ovesco Endoscopy (Germany).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 2.24 billion
- 2027 Estimated Market Size: USD 2.32 billion
- Projected Market Size: USD 3.35 billion by 2036
- Growth Forecast: 4.1% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: End Use (Hospitals) | Product (Ligation Clips)
- Emerging Opportunity Segment: End Use (Outpatient Facilities) | Product (Ligation Clips)
Market Growth Drivers and Industry Trends
Rising incidence of gastrointestinal bleeding and endoscopic procedures
The rising incidence of gastrointestinal bleeding and the growing use of endoscopic procedures are increasing demand for effective devices that can control bleeding during minimally invasive interventions. Endoscopic hemostasis techniques provide physicians with targeted approaches for managing bleeding lesions while reducing the need for more invasive surgical procedures. Increasing emphasis on early diagnosis and treatment of gastrointestinal disorders, combined with broader utilization of therapeutic endoscopy, is supporting demand for reliable hemostasis devices across clinical settings.
Technological innovations in hemostasis device design
Technological innovations in hemostasis device design are improving the precision, reliability, and versatility of bleeding control during endoscopic procedures. Developments in clips, thermal systems, injection-based techniques, and combination devices are enabling clinicians to address different bleeding patterns and anatomical challenges more effectively. Improvements in device ergonomics, deployment mechanisms, visualization, and compatibility with modern endoscopic systems are also supporting easier procedural handling and encouraging the adoption of advanced hemostasis technologies.
Expansion of hospital and endoscopy infrastructure in emerging regions
Expansion of hospital and endoscopy infrastructure in emerging regions is increasing access to diagnostic and therapeutic gastrointestinal procedures, creating additional demand for endoscopic hemostasis devices. Investments in healthcare facilities, specialist services, endoscopy units, and medical equipment are enabling more patients to receive minimally invasive treatment for gastrointestinal conditions. As clinical capabilities expand and awareness of advanced endoscopic interventions increases, healthcare providers are increasingly adopting specialized devices that support effective bleeding management and improve procedural outcomes.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising incidence of gastrointestinal bleeding and endoscopic procedures | 1.5% | Short term (≤ 2 yrs) | North America; Europe; Spillover: Asia Pacific | Medium | Fast |
| Technological innovations in hemostasis device design | 1% | Medium term (2–5 yrs) | North America; Europe; Spillover: Asia Pacific | Low | Moderate |
| Expansion of hospital and endoscopy infrastructure in emerging regions | 0.8% | Long term (5+ yrs) | Asia Pacific; Latin America; Spillover: MEA | Medium | Moderate |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
North America accounted for the largest share of the endoscopic hemostasis devices market, contributing 44.38% share in 2026, supported by advanced gastrointestinal care infrastructure, widespread adoption of minimally invasive procedures, and increasing demand for effective management of gastrointestinal bleeding. Hospitals and specialized healthcare facilities across the region have established capabilities for performing advanced endoscopic procedures, supporting the use of devices designed to control bleeding during therapeutic interventions. Growing prevalence of gastrointestinal disorders and increasing awareness of minimally invasive treatment approaches are also contributing to demand for endoscopic hemostasis technologies. In addition, continued improvements in endoscopic techniques and increasing preference for procedures that can reduce surgical intervention and support faster patient recovery are strengthening the adoption of hemostasis devices.
Asia Pacific (Fastest-Growing Region)
The Asia Pacific endoscopic hemostasis devices market is experiencing the fastest growth, driven by improving healthcare infrastructure, increasing adoption of minimally invasive gastrointestinal procedures, and rising awareness of advanced endoscopic treatment options. Expanding hospital networks and greater availability of specialized diagnostic and therapeutic services are enabling more patients to receive endoscopic management for gastrointestinal bleeding. The growing prevalence of gastrointestinal diseases is also increasing the need for effective hemostasis solutions across healthcare facilities. In addition, improvements in physician training and the adoption of advanced endoscopy techniques are supporting broader use of therapeutic devices. Rising healthcare expenditure and ongoing modernization of medical facilities are further strengthening demand for endoscopic hemostasis technologies across emerging healthcare markets in the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
United States 🇺🇸
Advanced Procedure AdoptionIn the U.S., demand for endoscopic hemostasis devices is supported by continued emphasis on effective management of gastrointestinal bleeding in hospital and ambulatory settings. Manufacturers prioritize differentiated clinical performance, procedural efficiency, compatibility with advanced endoscopy systems, and evidence supporting reduced intervention complexity.
Germany 🇩🇪
Precision Endoscopy DemandGermany’s market emphasizes reliable, technically advanced hemostasis solutions that fit established specialist endoscopy workflows. Purchasing decisions increasingly favor devices that provide procedural control, consistent clinical performance, and efficient treatment of complex gastrointestinal bleeding while meeting rigorous quality and regulatory expectations.
Japan 🇯🇵
Specialized Clinical InnovationJapan’s endoscopic hemostasis devices market is supported by extensive specialist expertise and continued refinement of minimally invasive gastrointestinal procedures. Product priorities include precise tissue interaction, compact device design, compatibility with sophisticated endoscopic techniques, and solutions suited to technically demanding bleeding management.
South Korea 🇰🇷
Technology-Driven ProceduresIn South Korea, adoption of endoscopic hemostasis devices is closely linked to technologically advanced hospital environments and demand for minimally invasive treatment. Manufacturers can differentiate through improved device handling, procedural visualization, compatibility with modern endoscopy platforms, and clinical efficiency in gastrointestinal bleeding control.
France 🇫🇷
Hospital Procurement FocusFrance’s endoscopic hemostasis devices market is strongly influenced by hospital-based purchasing and the need for clinically dependable treatment options. Commercial success depends on demonstrating procedural utility, cost-conscious use of disposable devices, compliance with clinical standards, and fit within established gastroenterology practices.
Italy 🇮🇹
Expanding Minimally Invasive CareIn Italy, demand for endoscopic hemostasis devices is tied to the continued use of minimally invasive gastrointestinal interventions across hospital networks. Suppliers are focused on dependable products that simplify bleeding control, support clinician efficiency, and provide practical compatibility with varying endoscopy infrastructure across healthcare facilities.
Endoscopic Hemostasis Devices Market Share (%), by End Use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd Use Segment Analysis: Hospitals (Largest Segment) vs Outpatient Facilities (Fastest-Growing Segment)
The hospitals segment accounted for a 62.24% share of the endoscopic hemostasis devices market in 2026, supported by the high volume of gastrointestinal procedures performed in hospital settings and the availability of advanced endoscopic infrastructure. Hospitals commonly manage complex bleeding cases that require immediate intervention, making reliable hemostasis devices an important component of procedural care. The presence of specialized gastroenterology units, trained clinical personnel, diagnostic imaging capabilities, and emergency treatment facilities further supports the adoption of endoscopic hemostasis technologies. In addition, the increasing use of minimally invasive approaches for managing gastrointestinal bleeding is encouraging hospitals to incorporate a broader range of endoscopic devices into routine and emergency procedures.
The outpatient facilities segment is expected to grow at the fastest pace in the endoscopic hemostasis devices market, as healthcare delivery increasingly shifts toward minimally invasive procedures performed outside traditional inpatient environments. Improvements in endoscopic visualization, device handling, procedural efficiency, and patient monitoring are enabling a wider range of bleeding-control interventions to be conducted in ambulatory settings. The preference for shorter recovery periods, reduced hospitalization requirements, and more convenient procedural care is supporting the expansion of outpatient endoscopy services. As outpatient facilities strengthen their procedural capabilities and adopt advanced hemostasis technologies, demand for compact, efficient, and easy-to-use devices is expected to increase.
Product Segment Analysis: Ligation Clips (Largest & Fastest-Growing Segment)
The ligation clips segment accounted for a 32.62% share of the endoscopic hemostasis devices market in 2026 and is expected to maintain strong growth, supported by the broad applicability of clips for controlling gastrointestinal bleeding during endoscopic procedures. Ligation clips provide a mechanical approach to hemostasis without relying on thermal energy or injected agents, making them suitable for a range of bleeding lesions and procedural situations. Their ability to provide targeted closure of blood vessels or bleeding sites, combined with relatively straightforward deployment through endoscopic systems, supports their adoption across different clinical settings. Increasing emphasis on minimally invasive bleeding management and the need for efficient procedural tools are further reinforcing demand for ligation clips. Continued improvements in clip design, deployment mechanisms, and compatibility with modern endoscopes are also supporting their use in increasingly diverse endoscopic interventions.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End Use | Hospitals, Outpatient Facilities | Hospitals | Outpatient Facilities |
| Product | Ligation Clips, Ligation Bands, Injection Needles, Hemostatic Spray, Thermal Probes, Argon Plasma Coagulation (APC), Radiofrequency Ablation (RFA) | Ligation Clips | Ligation Clips |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Analyst Perspective:
Clinical success in endoscopic hemostasis relies heavily on balancing rapid bleeding control with refined tactile control during high-acuity interventions. Manufacturers establish market leadership by engineering flexible, low-profile catheters that navigate tortuous gastrointestinal anatomy without obscuring visualization or causing collateral tissue trauma. Because procedure efficiency hinges on intuitive deployment mechanisms and precise handle feedback, devices offering predictable performance across diverse lesion types allow endoscopists to achieve secure hemostasis swiftly while minimizing re-bleeding risks and procedural complications.
Prominent players in the endoscopic hemostasis devices market:
- Boston Scientific (USA)
- Olympus (Japan)
- Medtronic (Ireland)
- Cook Medical (USA)
- CONMED (USA)
- Fujifilm (Japan)
- Erbe Elektromedizin (Germany)
- Micro-Tech Endoscopy (China)
- Steris (USA)
- Ovesco Endoscopy (Germany)
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Boston Scientific (USA) | |||||||
| Olympus (Japan) | |||||||
| Medtronic (Ireland) | |||||||
| Cook Medical (USA) | |||||||
| CONMED (USA) | |||||||
| Fujifilm (Japan) | |||||||
| Erbe Elektromedizin (Germany) | |||||||
| Micro-Tech Endoscopy (China) | |||||||
| Steris (USA) | |||||||
| Ovesco Endoscopy (Germany) |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Endoscopic Hemostasis Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Bleeding Severity | Mild Bleeding, Moderate Bleeding, Severe or Life-Threatening Bleeding |
| Bleeding Source | Upper Gastrointestinal Bleeding, Lower Gastrointestinal Bleeding, Small-Bowel Bleeding, Post-Procedure Bleeding |
| Purchasing Model | Direct Capital Purchase, Consumables-Based Purchase, Group Purchasing Organization (GPO) Purchase, Contract-Based Purchase |
Endoscopic Hemostasis Devices Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Procedure Workflow Optimization |
|
| Hospital Procurement & Tender Dynamics |
|
| Training & Skills Development Landscape |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
How large is the endoscopic hemostasis devices market?
How much is the endoscopic hemostasis devices industry expected to grow by 2036?
How are technological innovations influencing adoption of endoscopic hemostasis devices?
Why is endoscopy infrastructure expansion supporting demand for specialized hemostasis devices?
Why do hospitals dominate the endoscopic hemostasis devices market?
What is driving the rapid growth of outpatient facilities in the endoscopic hemostasis devices market?
How does North America maintain its lead in the endoscopic hemostasis devices market?
Why is Asia Pacific emerging as a high-growth market for endoscopic hemostasis devices?
Who are the leading players in the endoscopic hemostasis devices landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook